Online Registration only.
Open to anyone.
The Role of the Clinical Trial Patient in the Era of Personalized Medicine
The field of clinical research continues to accelerate and change at a rapid pace. Whether you work on the Sponsor, Clinical Research Organization (CRO) or site side of the industry, keeping up with anticipated changes and common trends is essential. This workshop aims to bring clinical research professionals together to connect and learn about the upcoming trends in clinical research.
Building off the 1st seminar on Personalized Medicine and Clinical Trials, on Tuesday, April 11th we plan to discuss ethical, legal and economic implications to the patient. In an interactive workshop setting with the patient being the center focus, we will discuss strategies on how to improve patient education, awareness, and access to care in the evolving field of personalized medicine in the clinical trial setting. Come join us as we discuss and problem solve real issues in clinical research!
Hosted By: Lauren Wall and Amanda Spratt
Lauren Wall, MS Director, Clinical Research Operations University of Chicago - Department of Medicine, Section of Hematology Oncology
Lauren has over 11 years of experience in Hematology/Oncology clinical research operations spanning industry and academic healthcare. Lauren currently oversees the clinical research operations in the section of Hematology Oncology at the University of Chicago. Her primary responsibilities include planning, organizing, directing, and overseeing daily clinical research for over 300+ clinical trials. Prior to taking her role in the academic setting, Lauren worked at an Oncology CRO where she gained experience in clinical trial monitoring, auditing and project management. Lauren holds an MSc degree in Clinical Research Administration from the George Washington University.
Amanda Spratt – Technical Director of the Cancer Center Regulatory and Compliance Office
Amanda recently assumed the position of Technical Director of the Cancer Center Regulatory and Compliance Office. Amanda received her BS in Biology from Boston College and has more than 12 years of experience in regulatory affairs and clinical cancer research. She has a detailed understanding of the framework of clinical cancer research, including protocol design, biomarker strategies, FDA submissions (IND/IDE), consent form development, and regulatory requirements of both clinical sites and commercial sponsors.